Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aegerion reports results from Phase 3 study of Juxtapid
Aegerion reports results from Phase 3 study of Juxtapid
Aegerion reports results from Phase 3 study of Juxtapid
Submitted by
admin
on November 19, 2013 - 7:27am
Source:
Yahoo/Fly on the Wall
News Tags:
Aegerion
Juxtapid
Homozygous Familial Hypercholesterolemia
Headline:
Aegerion reports results from Phase 3 study of Juxtapid
Do Not Allow Advertisers to Use My Personal information
